Both caffeinated and decaf coffee showed the protective effect against cognitive decline
Drinking coffee has previously been linked to a reduced risk of Alzheimer’s and Parkinson’s diseases. Now, scientists may be closer to understanding why.
New research from the Krembil Research Institute examines how coffee helps protect against long-term cognitive decline — and it turns out that the roast might matter.
A massive meta-analysis suggests that the benefits of daily coffee consumption outweigh the risk.
“The bottom line is that we suggest [coffee] can be a good part of a healthy diet.”
– Robin Poole, University of Southampton
Science continues to suggest that coffee is good for you.
Based on a systematic umbrella review of 201 meta-analyses recently published in the BMJ, researchers from the University of Southampton found that moderate coffee consumption was more often associated with benefit than harm.
Drinking three to four cups of coffee a day showed the greatest benefit in terms of cardiovascular disease, coronary heart disease, and stroke, versus not drinking coffee. (Drinking coffee beyond these amounts was not associated with harm, but the benefits were less pronounced.)
Report highlights coffee’s potential role in reducing cognitive decline
Moderate coffee consumption (3-5 cups per day) may protect against age-related cognitive decline and related neurodegenerative diseases such as Alzheimer’s and Parkinson’s, according to a new report from the Institute for Scientific Information on Coffee (ISIC).
This research supports mounting evidence suggesting that “long-term coffee intake could be a viable strategy for reducing the risk of Alzheimer’s disease, Parkinson’s disease, and other diseases associated with aging.”
Key highlights about coffee from the report include: Continue reading